Disclosure 0001238303-26-000002-1

SEC FORM 4

$4,690,741.44

REGENERON PHARMACEUTICALS, INC. (REGN)

Acquisition (code M) of 12,282 shares at $381.92 per share.

Reporting Person LAROSA JOSEPH J · Officer Title EVP General Counsel and Secret · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001238303-26-000002 · filed 2026-08-21 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "REGENERON PHARMACEUTICALS, INC. (REGN)." Disclosed 2026-08-21. https://desqlong.com/cards/0001238303-26-000002-1 (retrieved 2026-09-26).